CymaBay Therapeutics, Inc. announced the appointment of Dr. Éric Lefebvre to its Board of Directors. Dr. Lefebvre is serving as Chief Medical Officer of Pliant Therapeutics, Inc., a biopharmaceutical company, where he has served as such since May 2018. Prior to joining Pliant, Dr. Lefebvre served as the Vice President of Research and Development at Allergan plc, a global pharmaceutical company, from November 2016 until April 2018.
CymaBay Therapeutics, Inc.
Equities
CBAY
US23257D1037
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-13.31% | 16.5B | |
+2.44% | 13.39B | |
+27.89% | 11.1B |